When multiple potential partners say yeah nah, not interested., page-17

Yeah and don’t forget that @antibotter told this forum in very clear terms that he had insider knowledge that management had told him that DEP-Cabazitaxel would be licenced out before the end of Phase One in 2019.

So one can only assume that @antibotter was being a ‘little’ loose with the truth trying to drum up excitement, or alternatively Starpharma couldn’t find any company that wanted to develop it further.

So here we are almost 5 years later, and @antibotter is still throwing around statements that are not entirely accurate and are based on his assumptions dressed up as facts.